AKT1 and colorectal cancer: Resveratrol possesses anticancer activity through upregulating the bone morphogenetic protein 7 (BMP7) in order to inactivate the PI3K/Akt signaling pathway through partly suppressing the phosphorylation of PTEN in colorectal cancer.